|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Faber W, Sharafi S, Stockmann M, Denecke
T, Sinn B, Puhl G, Bahra M, Malinowski MB, Neuhaus P and Seehofer
D: Long-term results of liver resection for hepatocellular
carcinoma in noncirrhotic liver. Surgery. 153:510–517. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ikai I, Arii S, Kojiro M, Ichida T,
Makuuchi M, Matsuyama Y, Nakanuma Y, Okita K, Omata M, Takayasu K
and Yamaoka Y: Reevaluation of prognostic factors for survival
after liver resection in patients with hepatocellular carcinoma in
a Japanese nationwide survey. Cancer. 101:796–802. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guglielmi A, Ruzzenente A, Conci S,
Valdegamberi A, Vitali M, Bertuzzo F, De Angelis M, Mantovani G and
Iacono C: Hepatocellular carcinoma: Surgical perspectives beyond
the barcelona clinic liver cancer recommendations. World J
Gastroenterol. 20:7525–7533. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peng ZW, Guo RP, Zhang YJ, Lin XJ, Chen MS
and Lau WY: Hepatic resection versus transcatheter arterial
chemoembolization for the treatment of hepatocellular carcinoma
with portal vein tumor thrombus. Cancer. 118:4725–4736. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang T, Huang JW, Bai YN, Wu H and Zeng
Y: Recurrence and survivals following hepatic resection for
hepatocellular carcinoma with major portal/hepatic vein tumor
thrombus. Hepatol Res. 44:761–768. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Edmondson HA and Steiner PE: Primary
carcinoma of the liver: A study of 100 cases among 48,900
necropsies. Cancer. 7:462–503. 1954. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vauthey JN, Dixon E, Abdalla EK, et al:
Pretreatment assessment of hepatocellular carcinoma: Expert
consensus statement. HPB (Oxford). 12:289–299. 2010.PubMed/NCBI
|
|
9
|
Buck AK, Herrmann K, Eckel F and Beer AJ:
Pancreatic and hepatobiliary cancers. Methods Mol Biol.
727:243–264. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Regimbeau JM, Abdalla EK, Vauthey JN,
Lauwers GY, Durand F, Nagorney DM, Ikai I, Yamaoka Y and Belghiti
J: Risk factors for early death due to recurrence after liver
resection for hepatocellular carcinoma: results of a multicenter
study. J Surg Oncol. 85:36–41. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Masuda T, Beppu T, Ishiko T, et al:
Intrahepatic dissemination of hepatocellular carcinoma after local
ablation therapy. J Hepatobiliary Pancreat Surg. 15:589–595. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yan T, Zhao JJ, Bi XY, et al: Prognosis of
hepatocellular carcinoma: A study of 832 cases. Zhonghua Zhong Liu
Za Zhi. 35:54–58. 2013.(In Chinese). PubMed/NCBI
|
|
13
|
Duseja A: Staging of hepatocellular
carcinoma. J Clin Exp Hepatol. 4:S74–S79. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Poon RT, Fan ST, Lo CM, Liu CL and Wong J:
Difference in tumor invasiveness in cirrhotic patients with
hepatocellular carcinoma fulfilling the Milan criteria treated by
resection and transplantation: Impact on long-term survival. Ann
Surg. 245:51–58. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhong JH, Ke Y, Gong WF, Xiang BD, Ma L,
Ye XP, Peng T, Xie GS and Li LQ: Hepatic resection associated with
good survival for selected patients with intermediate and
advanced-stage hepatocellular carcinoma. Ann Surg. 260:329–340.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ishizawa T, Hasegawa K, Aoki T, Takahashi
M, Inoue Y, Sano K, Imamura H, Sugawara Y, Kokudo N and Makuuchi M:
Neither multiple tumors nor portal hypertension are surgical
contraindications for hepatocellular carcinoma. Gastroenterology.
134:1908–1916. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang BW, Mok KT, Liu SI, Chou NH, Tsai CC,
Chen IS, Yeh MH and Chen YC: Is hepatectomy beneficial in the
treatment of multinodular hepatocellular carcinoma? J Formos Med
Assoc. 107:616–626. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lai ECH and Lau WY: Spontaneous rupture of
hepatocellular carcinoma: A systematic review. Arch Surg.
141:191–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Matono R, Yoshiya S, Motomura T, Toshima
T, Kayashima H, Masuda T, Yoshizumi T, Taketomi A, Shirabe K and
Maehara Y: Factors linked to longterm survival of patients with
hepatocellular carcinoma accompanied by tumour thrombus in the
major portal vein after surgical resection. HPB (Oxford).
14:247–253. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sorrentino P, Tarantino L, D'Angelo S,
Terracciano L, Ferbo U, Bracigliano A, Panico L, De Chiara G,
Lepore M, De Stefano N, et al: Validation of an extension of the
international non-invasive criteria for the diagnosis of
hepatocellular carcinoma to the characterization of macroscopic
portal vein thrombosis. J Gastroenterol Hepatol. 26:669–677. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou L, Rui JA, Wang SB, Chen SG and Qu Q:
Prognostic factors of solitary large hepatocellular carcinoma: The
importance of differentiation grade. Eur J Surg Oncol. 37:521–525.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Santambrogio R, Opocher E, Costa M,
Barabino M, Zuin M, Bertolini E, De Filippi F and Bruno S: Hepatic
resection for ‘BCLC stage A’ hepatocellular carcinoma. The
prognostic role of α-fetoprotein. Ann Surg Oncol. 19:426–434. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim HS, Park JW, Jang JS, Kim HJ, Shin WG,
Kim KH, Lee JH, Kim HY and Jang MK: Prognostic values of
alpha-fetoprotein and protein induced by vitamin K absence or
antagonist-II in hepatitis B virus-related hepatocellular
carcinoma: A prospective study. J Clin Gastroenterol. 43:482–488.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shi M, Guo RP, Lin XJ, Zhang YQ, Chen MS,
Zhang CQ, Lau WY and Li JQ: Partial hepatectomy with wide versus
narrow resection margin for solitary hepatocellular carcinoma: A
prospective randomized trial. Ann Surg. 245:36–43. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang J, Xu LB, Liu C, Pang HW, Chen YJ and
Ou QJ: Prognostic factors and outcome of 438 Chinese patients with
hepatocellular carcinoma underwent partial hepatectomy in a single
center. World J Surg. 34:2434–2441. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu L, Miao R, Yang H, Lu X, Zhao Y, Mao
Y, Zhong S, Huang J, Sang X and Zhao H: Prognostic factors after
liver resection for hepatocellular carcinoma: A single-center
experience from China. Am J Surg. 203:741–750. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Giuliante F, Ardito F, Pinna AD, Sarno G,
Giulini SM, Ercolani G, Portolani N, Torzilli G, Donadon M,
Aldrighetti L, et al: Liver resection for hepatocellular carcinoma
≤3 cm: Results of an Italian multicenter study on 588 patients. J
Am Coll Surg. 215:244–254. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheng SQ, Wu MC, Chen H, Shen F, Yang JH,
Cong WM, Wang PJ and Zhao YX: Significance of typing of tumor
thrombi in determination of treatment and assessment of prognosis
of hepatocellular carcinoma with tumor thrombi in the portal vein.
Zhonghua Yi Xue Za Zhi. 84:3–5. 2004.(In Chinese). PubMed/NCBI
|
|
29
|
Shi J, Lai EC, Li N, Guo WX, Xue J, Lau
WY, Wu MC and Cheng SQ: A new classification for hepatocellular
carcinoma with portal vein tumor thrombus. J Hepatobiliary Pancreat
Sci. 18:74–80. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chung GE, Lee JH, Kim HY, Hwang SY, Kim
JS, Chung JW, Yoon JH, Lee HS and Kim YJ: Transarterial
chemoembolization can be safely performed in patients with
hepatocellular carcinoma invading the main portal vein and may
improve the overall survival. Radiology. 258:627–634. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Maida M, Orlando E, Cammà C and Cabibbo G:
Staging systems of hepatocellular carcinoma: A review of
literature. World J Gastroenterol. 20:4141–4150. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kinoshita A, Onoda H, Imai N, Iwaku A,
Oishi M, Tanaka K, Fushiya N, Koike K, Nishino H, Matsushima M, et
al: The Glasgow Prognostic Score, an inflammation based prognostic
score, predicts survival in patients with hepatocellular carcinoma.
BMC Cancer. 13:522013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu C, Xiao GQ, Yan LN, Li B, Jiang L, Wen
TF, Wang WT, Xu MQ and Yang JY: Value of α-fetoprotein in
association with clinicopathological features of hepatocellular
carcinoma. World J Gastroenterol. 19:1811–1819. 2013. View Article : Google Scholar : PubMed/NCBI
|
